PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

GLENMEDE TRUST CO NA's Holding History (CIK: 0000314949)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 12,755 Value ($000) $1,114 Avg Close $81.85 Range $62.24 - $96.54

Q1 2025

Shares 20,666 Value ($000) $999 Avg Close $41.90 Range $33.70 - $60.60

Q4 2024

Shares 8,953 Value ($000) $346 Avg Close $43.60 Range $33.31 - $48.89

Q3 2024

Shares 14,981 Value ($000) $674 Avg Close $40.40 Range $32.50 - $48.00

Q2 2024

Shares 15,506 Value ($000) $537 Avg Close $29.29 Range $24.22 - $35.96

Q1 2024

Shares 11,451 Value ($000) $331 Avg Close $27.21 Range $21.43 - $33.34

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	12,755	$1,114	$81.85	$62.24 - $96.54
Q1 2025	20,666	$999	$41.90	$33.70 - $60.60
Q4 2024	8,953	$346	$43.60	$33.31 - $48.89
Q3 2024	14,981	$674	$40.40	$32.50 - $48.00
Q2 2024	15,506	$537	$29.29	$24.22 - $35.96
Q1 2024	11,451	$331	$27.21	$21.43 - $33.34